Haemonetics Corporation (HAE) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $90.80 +0.46%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Haemonetics Corporation (NYSE: HAE) reported Q3 EPS of $0.53, $0.02 better than the analyst estimate of $0.51. Revenue for the quarter came in at $231.8 million versus the consensus estimate of $234.85 million.
For earnings history and earnings-related data on Haemonetics Corporation (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Rothschild Redburn Upgrades Apple (AAPL) to Buy
- JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
